Losers in Focus: Cirrus Logic, Inc. (NASDAQ:CRUS), Cell Therapeutics Inc, ArcelorMittal, Swift Energy Company

Lakeway, NY -- (SBWIRE) -- 02/21/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Cirrus Logic, Inc. (NASDAQ:CRUS) moved down 7.07% and closed at $25.36. Cirrus Logic Inc. is moving forward with plans to expand its downtown Austin footprint. The firm told the American-Statesman it has purchased almost a half a block just west of its six-story headquarters for future expansion.

The Law Offices of Todd M. Garber is investigating potential claims against Cirrus Logic, Inc. concerning possible violations of federal securities laws. The investigation focuses on allegations that certain statements issued by Cirrus between July 31, 2012 and October 31, 2012 were false and misleading concerning the Company's business and financial prospects.

How Should Investors Trade CRUS After The Recent Price movement? Find out Here

Cell Therapeutics Inc. (NASDAQ:CTIC) went down 1.42% and closed at $1.36. In the last one year, the stock is down over 79%. The 52-week range for the stock is $1.14 and $8.25. Cell Therapeutics develops acquires and commercializes treatments for cancer. The Company’s research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer.

Is CTIC a Strong Buying Opportunity After The Recent Slump? Find out Here

ArcelorMittal (ADR) (NYSE:MT) moved down 4.91% and the last traded price was $15.68. The EU Commission said that CEO Lakshmi Mittal agreed after talks with Industrial Commissioner Antonio Tajani to suspend all restructuring programs until the body publishes its plan to help Europe's steel industry this summer.

RBC Capital increased the rating on the stock to outperform from sector perform.

Is MT a Pump & Dump Story? Let’s Find out Here

Swift Energy Company (NYSE:SFY) went down 4.91% and closed at $14.34. The Company reported fourth quarter earnings from continuing operations of $11.2 million or $0.26 per diluted share compared to fourth quarter 2011 earnings from continuing operations of $20.7 million, or $0.48 per diluted share. Adjusted cash flow for the fourth quarter of 2012 decreased 8% to $91.4 million.

Is SFY a Strong Buying Opportunity After The Recent Gain? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.